Synairgen Plc (SNG.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Accounts receivable | 81 | 426 | -548 | 17 | -18 |
| Other Working Capital | 809 | 100 | -306 | -58 | 423 |
| Other Operating Activity | -3,786 | -4,349 | 2,921 | -2,947 | -2,338 |
| Operating Cash Flow | $-2,896 | $-3,823 | $2,067 | $-2,988 | $-1,933 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -10 | -386 | -6 | -5 | -10 |
| Other Investing Activity | 76 | 1,977 | -320 | 2,104 | 3,088 |
| Investing Cash Flow | $66 | $1,591 | $-326 | $2,099 | $3,078 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 0 | 2,880 | 0 | 1 | 0 |
| Other Financing Activity | 0 | -209 | 0 | 0 | 0 |
| Financing Cash Flow | $0 | $2,671 | $0 | $1 | $0 |
| Beginning Cash Position | 5,284 | 4,845 | 3,104 | 3,992 | 2,847 |
| End Cash Position | 2,454 | 5,284 | 4,845 | 3,104 | 3,992 |
| Net Cash Flow | $-2,830 | $439 | $1,741 | $-888 | $1,145 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,896 | -3,823 | 2,067 | -2,988 | -1,933 |
| Capital Expenditure | -10 | -386 | -6 | -5 | -10 |
| Free Cash Flow | -2,906 | -4,209 | 2,061 | -2,993 | -1,943 |